NEW YORK (GenomeWeb News) – The National Cancer Institute said on Monday that it plans to use $10 million to fund new research projects by small businesses that focus on specific high-priority areas where new devices and technologies are needed to support cancer diagnosis and treatment.

Funded under the Small Business Innovation Research (SBIR) program, the new grants will support projects to develop a range of technologies that are based on genomic, proteomic, and metabolomic discoveries, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.